Progestin News and Research

RSS
FDA approves Watson's ANDA for Next Choice ONE DOSE emergency contraceptive

FDA approves Watson's ANDA for Next Choice ONE DOSE emergency contraceptive

Male hormonal contraceptives applied daily to the skin reduce sperm production

Male hormonal contraceptives applied daily to the skin reduce sperm production

Apigenin effective against human breast cancer

Apigenin effective against human breast cancer

Endocrine Society and its Hormone Health Network release ‘Menopause Map’

Endocrine Society and its Hormone Health Network release ‘Menopause Map’

Injectable form of progestin may increase breast cancer risk in young women

Injectable form of progestin may increase breast cancer risk in young women

Bayer receives FDA approval for lower dose formulation of ANGELIQ

Bayer receives FDA approval for lower dose formulation of ANGELIQ

Quitting hormone therapy can lead to breast tumor regression

Quitting hormone therapy can lead to breast tumor regression

DMPA intake may increase risk of periodontitis, gingivitis in women

DMPA intake may increase risk of periodontitis, gingivitis in women

Breast cancer risks and management updates

Breast cancer risks and management updates

Combo hormone therapy increases risk of breast cancer in women with new-onset tenderness

Combo hormone therapy increases risk of breast cancer in women with new-onset tenderness

Merck's NEXPLANON 68 mg now available in the U.S.

Merck's NEXPLANON 68 mg now available in the U.S.

New onset tenderness after combo hormone therapy increases risk of breast cancer

New onset tenderness after combo hormone therapy increases risk of breast cancer

LA BioMed andrologist leads new male contraceptive Phase I clinical study

LA BioMed andrologist leads new male contraceptive Phase I clinical study

Teva's ZOELY oral contraceptive receives EU Marketing Authorization

Teva's ZOELY oral contraceptive receives EU Marketing Authorization

Post-menopausal women with CAD are at increased risk for SCD: Study

Post-menopausal women with CAD are at increased risk for SCD: Study

Birth control pill safety issues raised

Birth control pill safety issues raised

EMAS publishes position statement on women's post-reproductive health problems in Maturitas journal

EMAS publishes position statement on women's post-reproductive health problems in Maturitas journal

Watson launches Generess Fe low-dose oral contraceptives in the U.S.

Watson launches Generess Fe low-dose oral contraceptives in the U.S.